Estrogen support complexes
Formulations containing phytoestrogens (soy isoflavones, red clover, black cohosh, hops), lignans, and other botanical oestrogen modulators marketed for menopausal symptoms and women's hormonal health. Pharmacological activity confirmed for several components.
How it works (mechanism of action)
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
CONTRAINDICATED in oestrogen receptor-positive (ER+) breast cancer, endometrial cancer, uterine fibroids, endometriosis — phytooestrogenic components may stimulate oestrogen-dependent pathways. Drug interactions: tamoxifen, aromatase inhibitors, HRT. Hepatotoxicity reported with black cohosh. Pregnancy: CONTRAINDICATED. Requires individualised risk-benefit assessment.
